Piper Sandler lifts Aclaris Therapeutics Inc [ACRS] price estimate. Who else is bullish?
Aclaris Therapeutics Inc [NASDAQ: ACRS] price surged by 53.17 percent to reach at $1.09. The one-year ACRS stock forecast points to a potential downside of -25.6. The average equity rating for ACRS stock is currently 3.00, trading closer to a bullish pattern in the stock